174 related articles for article (PubMed ID: 34342289)
1. Impact of Surgeon Type and Rurality on Treatment and Survival of Ovarian Cancer Patients.
Weeks KS; Lynch CF; West MM; Carnahan RM; O'Rorke MA; Oleson JJ; McDonald ME; Charlton ME
Am J Clin Oncol; 2021 Oct; 44(10):544-551. PubMed ID: 34342289
[TBL] [Abstract][Full Text] [Related]
2. Rural disparities in surgical care from gynecologic oncologists among Midwestern ovarian cancer patients.
Weeks K; Lynch CF; West M; Carnahan R; O'Rorke M; Oleson J; McDonald M; Stewart SL; ; Charlton M
Gynecol Oncol; 2021 Feb; 160(2):477-484. PubMed ID: 33218682
[TBL] [Abstract][Full Text] [Related]
3. Gynecologic oncologist impact on adjuvant chemotherapy care for stage II-IV ovarian cancer patients.
Weeks KS; Lynch CF; West M; Carnahan R; O'Rorke M; Oleson J; McDonald M; Stewart SL; ; Charlton M
Gynecol Oncol; 2022 Jan; 164(1):3-11. PubMed ID: 34776243
[TBL] [Abstract][Full Text] [Related]
4. Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients.
Earle CC; Schrag D; Neville BA; Yabroff KR; Topor M; Fahey A; Trimble EL; Bodurka DC; Bristow RE; Carney M; Warren JL
J Natl Cancer Inst; 2006 Feb; 98(3):172-80. PubMed ID: 16449677
[TBL] [Abstract][Full Text] [Related]
5. Fertility preservation and survival among young women with early ovarian cancer living in US counties with gynecologic oncologist services.
Hillman RT; Saenz CC; McHale MT; Plaxe SC
Int J Gynaecol Obstet; 2017 May; 137(2):157-163. PubMed ID: 28170079
[TBL] [Abstract][Full Text] [Related]
6. Influence of the gynecologic oncologist on the survival of ovarian cancer patients.
Chan JK; Kapp DS; Shin JY; Husain A; Teng NN; Berek JS; Osann K; Leiserowitz GS; Cress RD; O'Malley C
Obstet Gynecol; 2007 Jun; 109(6):1342-50. PubMed ID: 17540806
[TBL] [Abstract][Full Text] [Related]
7. Association of Distance to Gynecologic Oncologist and Survival in a Rural Midwestern State.
Ulmer KK; Greteman B; McDonald M; Gonzalez Bosquet J; Charlton ME; Nash S
Womens Health Rep (New Rochelle); 2022; 3(1):678-685. PubMed ID: 36147832
[TBL] [Abstract][Full Text] [Related]
8. Quality of care in advanced ovarian cancer: the importance of provider specialty.
Mercado C; Zingmond D; Karlan BY; Sekaris E; Gross J; Maggard-Gibbons M; Tomlinson JS; Ko CY
Gynecol Oncol; 2010 Apr; 117(1):18-22. PubMed ID: 20106512
[TBL] [Abstract][Full Text] [Related]
9. A population-based study of patterns of care for ovarian cancer: who is seen by a gynecologic oncologist and who is not?
Carney ME; Lancaster JM; Ford C; Tsodikov A; Wiggins CL
Gynecol Oncol; 2002 Jan; 84(1):36-42. PubMed ID: 11748973
[TBL] [Abstract][Full Text] [Related]
10. Outcomes in surgery for ovarian cancer.
Elit L; Bondy SJ; Paszat L; Przybysz R; Levine M
Gynecol Oncol; 2002 Dec; 87(3):260-7. PubMed ID: 12468323
[TBL] [Abstract][Full Text] [Related]
11. Rural residence is related to shorter survival in epithelial ovarian cancer patients.
Lutgendorf SK; Ramirez E; Schrepf A; Valentine MC; Charlton M; Zimmerman MB; Goodheart MJ; Zia S; Sood AK; Thaker PH
Gynecol Oncol; 2021 Oct; 163(1):22-28. PubMed ID: 34400004
[TBL] [Abstract][Full Text] [Related]
12. Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinoma.
Engelen MJ; Kos HE; Willemse PH; Aalders JG; de Vries EG; Schaapveld M; Otter R; van der Zee AG
Cancer; 2006 Feb; 106(3):589-98. PubMed ID: 16369985
[TBL] [Abstract][Full Text] [Related]
13. What changes in the organisation of cancer services will improve the outcome for women with ovarian cancer?
Woodman C; Baghdady A; Collins S; Clyma JA
Br J Obstet Gynaecol; 1997 Feb; 104(2):135-9. PubMed ID: 9070126
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with the suboptimal treatment of women less than 55 years of age with early-stage ovarian cancer.
Chan JK; Kapp DS; Shin JY; Osann K; Leiserowitz GS; Cress RD; O'Malley C
Gynecol Oncol; 2008 Jan; 108(1):95-9. PubMed ID: 17949796
[TBL] [Abstract][Full Text] [Related]
15. Factor Analysis of Health Care Access With Ovarian Cancer Surgery and Gynecologic Oncologist Consultation.
Gupta A; Chen Q; Wilson LE; Huang B; Pisu M; Liang M; Previs RA; Moss HA; Ward KC; Schymura MJ; Berchuck A; Akinyemiju TF
JAMA Netw Open; 2023 Feb; 6(2):e2254595. PubMed ID: 36723938
[TBL] [Abstract][Full Text] [Related]
16. Interval debulking surgery is not worth the wait: a National Cancer Database study comparing primary cytoreductive surgery versus neoadjuvant chemotherapy.
Lyons YA; Reyes HD; McDonald ME; Newtson A; Devor E; Bender DP; Goodheart MJ; Gonzalez Bosquet J
Int J Gynecol Cancer; 2020 Jun; 30(6):845-852. PubMed ID: 32341114
[TBL] [Abstract][Full Text] [Related]
17. Secondary cytoreduction followed by chemotherapy versus chemotherapy alone in platinum-sensitive relapsed ovarian cancer (SOC-1): a multicentre, open-label, randomised, phase 3 trial.
Shi T; Zhu J; Feng Y; Tu D; Zhang Y; Zhang P; Jia H; Huang X; Cai Y; Yin S; Jiang R; Tian W; Gao W; Liu J; Yang H; Cheng X; Zang R
Lancet Oncol; 2021 Apr; 22(4):439-449. PubMed ID: 33705695
[TBL] [Abstract][Full Text] [Related]
18. The impact of expanding gynecologic oncology care to ovarian cancer patients in small cities and rural communities.
Swayze EJ; Strzyzewski L; Avula P; Zebolsky AL; Hoekstra AV
Gynecol Oncol; 2021 Jun; 161(3):852-857. PubMed ID: 33888339
[TBL] [Abstract][Full Text] [Related]
19. Ovarian cancer staging: does it require a gynecologic oncologist?
Mayer AR; Chambers SK; Graves E; Holm C; Tseng PC; Nelson BE; Schwartz PE
Gynecol Oncol; 1992 Nov; 47(2):223-7. PubMed ID: 1468701
[TBL] [Abstract][Full Text] [Related]
20. Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study.
Eisenkop SM; Friedman RL; Wang HJ
Gynecol Oncol; 1998 May; 69(2):103-8. PubMed ID: 9600815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
